Citron Research's Andrew Left went on CNBC's Halftime Report to talk about why he's long Valeant Pharmaceuticals now, but the interview veered off in a different direction. Left couldn't stop ...
Citron Research founder Andrew Left is shorting ... shareholders harassed him. But Left, who made his name with big bets against the pharmaceutical giant Valeant and China’s now-defunct property ...
Federal prosecutors on Friday charged famed short seller Andrew ... at Valeant was later convicted of involvement in a kickback scheme that funneled business to the pharmacies. Left’s indictment ...
His tweets send share prices plummeting, his TV interviews keep Wall Streeters glued to their screens, and his research reports worry his mother. That's right. Andrew Left's mom worries for his ...
Fresh accusations by federal authorities that one of the industry’s most prominent players, Andrew Left ... Examples include Valeant Pharmaceuticals, which Left accused of being at the center ...